📰 Rom News
Page 662 - Rom News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Rom. Real-time updates on events, politics, business and more.
May 4, 2023
Tata Steel expects its European operations to improve from the next quarter on the back of falling energy costs, its chief executive and managing director said on Thursday.... | May 4, 2023
May 4, 2023
Volker Bosse from Baader Bank retains his positive opinion on the stock with a Buy rating. The target price remains set at EUR 50. | May 4, 2023
May 4, 2023
Netel Holding reports that the companys Annual General Meeting date as above, resolved in accordance with all proposals from the Board of Directors and the Nomination Committee. The AGM adopted the... | May 4, 2023
May 4, 2023
A look at the day ahead in U.S. and global markets from Mike Dolan | May 4, 2023
May 4, 2023
Schroder Oriental Income Fund Ltd - Asia Pacific-focused investor - Pretax profit in the six months ended February 28 rises to GBP10.4 million from GBP8.3 million a year earlier. Income from... | May 4, 2023
May 4, 2023
Already positive, the research from Bernstein and its analyst Trevor Stirling still consider the stock as a Buy opportunity. The target price remains set at EUR 70. | May 4, 2023
May 4, 2023
Already positive, the research from Credit Suisse and its analyst Jon Peace still consider the stock as a Buy opportunity. The target price continues to be set at EUR 78. | May 4, 2023
May 4, 2023
In the Q1 2023 the companies in the economic group of Monbat AD have generated consolidated net sales revenue from continuing operations in the amount of BGN 104 464 thousand, an increase of... | May 4, 2023
May 4, 2023
Moncler Spa reported Thursday that it reported consolidated group revenues of EUR726.4 million in the first quarter of the year, up 23 percent from EUR589.9 million in the same period last year. For... | May 4, 2023
May 4, 2023
Issuer: Immunic, Inc. / Key word(s): Study results Immunic Reports Positive Results From Phase 1b Clinical Trial of IMU-856 in Celiac Disease, Providing Clinical Proof-of-Concept for New Therapeutic